A 2023 study in Diabetes, Obesity & Metabolism hinted that some patients can achieve significant appetite suppression and glycemic improvements even before reaching full therapeutic doses
Among the plethora of novel agents against diabetes, GLP-1RAs are known to exert various biological effects in extra-pancreatic tissues beyond controlling hyperglycemia ( via central mechanisms ( Similarly, SGLT-2is, also referred to as gliflozins, represent another class of anti-hyperglycemic agents currently used in T2D treatment with favorable effects on body weight
Puerarin exhibits a wide range of antioxidant activities in cardiovascular diseases, diabetes, obesity, osteoporosis, and other diseases (Xu et al., 2021
Maternal Serum Vitamin B12 during Pregnancy and Offspring Autism Spectrum Disorder
Research suggests that glutathione levels are often at their highest during restorative sleep stages